Microfluidics: A new tool for modeling cancer-immune interactions

Area of Science:

• Oncology
• Immunology
• Biotechnology

Background:

• Cancer immunotherapies show great promise, accelerating research into tumor-immune cell interactions.
• Several drugs that slow cancer progression have been approved by the FDA.
• Immune cells can impact cancer metastasis through various cellular and molecular mechanisms.

Purpose of the Study:

• To review current microfluidic assays for studying cancer immunotherapy.
• To discuss the development of novel microfluidic technologies for immunotherapy research.

Main Methods:

• Review of existing literature on microfluidic systems and immunotherapy assays.
• Analysis of the advantages of microfluidic technologies in recapitulating 3D tumor-immune interactions.
• Discussion of real-time monitoring and microenvironment control in microfluidic models.

Main Results:

• Microfluidic technologies provide unique advantages for studying complex cell interactions.
• These systems allow for precise control over the microenvironment and real-time monitoring.
• Microfluidics can effectively model key aspects of the metastatic cascade and immune cell interactions.

Conclusions:

• Microfluidic technologies are valuable tools for advancing cancer immunotherapy research.
• Further development of microfluidic platforms will enhance the study of tumor-immune dynamics.
• These advanced models hold potential for the development of new immunotherapeutic strategies.